Dura Substitute 510(k)s Should Not Require Follow-Up Imaging - FDA Panel
This article was originally published in The Gray Sheet
Executive Summary
One-year follow-up imaging in patients with implanted dura substitute devices has little clinical value in performance assessment, members of FDA's Neurological Devices Panel agreed at a Sept. 16 meeting in Gaithersburg, Maryland.